Digestive Disease Week
Digestive Disease Week
May 24, 2016
3 min watch
Save

VIDEO: Intense FMT induces remission in patients with resistant UC

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO — In this exclusive video from DDW 2016, Sudarshan Paramsothy, MD, from St. Vincent’s Clinical School, University of South Wales, Australia, discusses randomized controlled trial data showing intense multi-donor fecal microbiota transplantation was effective for inducing clinical and endoscopic remission in patients with resistant active ulcerative colitis.

“Our trial involved intensive fecal microbiota transplantation performed in a randomized double blind controlled study. Patients with active ulcerative colitis were randomized in a one-to-one manner to either FMT or placebo therapy,” he said. “We found that patients who received fecal microbiota transplantation had a significant improvement in their outcomes compared to the patients who were randomized to the placebo arm.”

Reference:

Paramsothy S, et al. Abstract #600. Presented at: Digestive Disease Week; May 21-24, 2016; San Diego.

Disclosures: Paramsothy reports no relevant financial disclosures.